+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United Kingdom Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests

  • PDF Icon

    Report

  • 54 Pages
  • May 2026
  • Region: United Kingdom
  • GlobalData
  • ID: 6108284
Description Jump to:

United Kingdom Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests

Summary

The analyst’s “United Kingdom Metabolic Disorders Market Outlook to 2036” is a comprehensive databook report, covering key market data on the United Kingdom Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Diabetes Assays, Cholesterol Tests

The United Kingdom Metabolic Disorders Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Metabolic Disorders Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Metabolic Disorders is segmented as follows:

  • Diabetes Assays
  • Cholesterol Tests

Reasons to Buy

The United Kingdom Metabolic Disorders Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Metabolic Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Metabolic Disorders Market, United Kingdom
2.1 Metabolic Disorders Market, United Kingdom, Revenue ($m), 2024-2036
2.1.1 Cholesterol Tests Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
2.1.2 Diabetes Assays Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
2.2 Metabolic Disorders Market, United Kingdom, Volume (Units), 2024-2036
2.2.1 Cholesterol Tests Market, United Kingdom, Volume (Units), by Segment, 2024-2036
2.2.2 Diabetes Assays Market, United Kingdom, Volume (Units), by Segment, 2024-2036
2.3 Metabolic Disorders Market, United Kingdom, Average Price ($), 2024-2036
2.4 Metabolic Disorders Market, United Kingdom, Company Share by Revenue ($m), 2025
3 Metabolic Disorders Market Pipeline Products
3.1 Metabolic Disorders Market Pipeline Products
3.2 Metabolic Disorders - Pipeline Products by Stage of Development
3.3 Metabolic Disorders - Pipeline Products by Segment
3.4 Metabolic Disorders - Pipeline Products by Territory
3.5 Metabolic Disorders - Pipeline Products by Regulatory Path
3.6 Metabolic Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in United Kingdom, Metabolic Disorders Market
4.1 Siemens Healthineers AG
4.1.1 Company Overview
4.2 Roche Diagnostics International Ltd
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Beckman Coulter Inc
4.4.1 Company Overview
4.5 Ortho Clinical Diagnostics Holdings Ltd (Inactive)
4.5.1 Company Overview
4.6 Danaher Corp
4.6.1 Company Overview
4.7 Thermo Fisher Scientific Inc
4.7.1 Company Overview
5 Appendix
5.1 Research Methodology
5.1.1 Coverage
5.1.2 Secondary Research
5.1.3 Primary Research
5.1.4 Market Modeling and Forecasting
5.1.5 Company Share Analysis
5.1.6 Benchmarking
5.2 the Analyst Consulting
5.3 Contact Us
5.4 Disclaimer
List of Tables
Table 1: Metabolic Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 2: Cholesterol Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 3: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 4: Metabolic Disorders Market, United Kingdom, Volume (Units), 2024-2036
Table 5: Cholesterol Tests Market, United Kingdom, Volume (Units), 2024-2036
Table 6: Diabetes Assays Market, United Kingdom, Volume (Units), 2024-2036
Table 7: Metabolic Disorders Market, United Kingdom, Average Price ($), 2024-2036
Table 8: Metabolic Disorders Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Metabolic Disorders Market Pipeline Products
Table 10: Metabolic Disorders - Pipeline Products by Stage of Development
Table 11: Metabolic Disorders Companies - Pipeline Products by Stage of Development
Table 12: Metabolic Disorders - Pipeline Products by Segment
Table 13: Metabolic Disorders - Pipeline Products by Territory
Table 14: Metabolic Disorders - Pipeline Products by Regulatory Path
Table 15: Metabolic Disorders - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Metabolic Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cholesterol Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 3: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 4: Metabolic Disorders Market, United Kingdom, Volume (Units), 2024-2036
Figure 5: Cholesterol Tests Market, United Kingdom, Volume (Units), 2024-2036
Figure 6: Diabetes Assays Market, United Kingdom, Volume (Units), 2024-2036
Figure 7: Metabolic Disorders Market, United Kingdom, Company Share (%), 2025
Figure 8: Metabolic Disorders - Pipeline Products by Stage of Development
Figure 9: Metabolic Disorders - Pipeline Products by Segment
Figure 10: Metabolic Disorders - Pipeline Products by Territory
Figure 11: Metabolic Disorders - Pipeline Products by Regulatory Path
Figure 12: Metabolic Disorders - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens Healthineers AG
  • Roche Diagnostics International Ltd
  • Abbott Laboratories
  • Beckman Coulter Inc
  • Ortho Clinical Diagnostics Holdings Ltd (Inactive)
  • Danaher Corp
  • Thermo Fisher Scientific Inc

Related Topics

Related Reports

EU5 Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests - Product Image

EU5 Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests

  • Report
  • 161 Pages
  • Europe
From
Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • 52 Pages
  • Global
From
Europe Diabetes Management Supplements Market Outlook, 2030 - Product Image

Europe Diabetes Management Supplements Market Outlook, 2030

  • Report
  • 100 Pages
  • Europe
From
Diabetes Management Supplements Market Outlook, 2030 - Product Image

Diabetes Management Supplements Market Outlook, 2030

  • Report
  • 187 Pages
  • Global
From
Type 2 Diabetes Mellitus Treatment Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

Type 2 Diabetes Mellitus Treatment Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 400 Pages
  • Global
From

About the Metabolic Disorder Market

Metabolic disorders are a group of conditions that affect the body's ability to produce or respond to hormones that regulate metabolism. These disorders can affect the body's ability to break down and use carbohydrates, proteins, and fats, as well as its ability to regulate blood sugar levels. Endocrinology is the branch of medicine that deals with the diagnosis and treatment of metabolic disorders. Endocrinologists diagnose and treat a wide range of metabolic disorders, including diabetes, thyroid disorders, and obesity. Metabolic disorders can have a significant impact on a person's quality of life, and can lead to serious health complications if left untreated. Treatment for metabolic disorders typically involves lifestyle changes, such as diet and exercise, as well as medications and other therapies. Companies in the metabolic disorder market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.